SEC Form 4 · accession 0001209191-17-045911
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven H Stein
Officer — EVP & Chief Medical Officer
Period of report
Jul 20, 2017
Accepted (ET)
Jul 21, 2017 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2017 | M | 1,191 | $88.68 | A | 19,356 | D | |
| Common Stock | Jul 20, 2017 | M | 4,772 | $83.83 | A | 24,128 | D | |
| Common Stock | Jul 20, 2017 | M | 522 | $95.76 | A | 24,650 | D | |
| Common StockF1,F2,F3 | Jul 20, 2017 | S | 1,191 | $131.09 | D | 23,459 | D | |
| Common StockF1,F2,F3 | Jul 20, 2017 | S | 4,772 | $131.09 | D | 18,687 | D | |
| Common StockF1,F2,F3,F4 | Jul 20, 2017 | S | 522 | $131.09 | D | 18,165 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $88.68 | Jul 20, 2017 | M | 1,191 | D | — | Mar 1, 2022 | Common Stock | 1,191 | 8,687 | D |
| Non-Qualified Stock Option (right to buy)F6 | $83.83 | Jul 20, 2017 | M | 4,772 | D | — | Jul 14, 2026 | Common Stock | 4,772 | 13,723 | D |
| Non-Qualified Stock Option (right to buy)F7 | $95.76 | Jul 20, 2017 | M | 522 | D | — | Jan 6, 2023 | Common Stock | 522 | 8,870 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- F2Represents weighted average sale price. Actual sale prices ranged from $129.57 - $132.10.
- F3Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- F4This includes an 18,165 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested
- F5Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- F6Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- F7Beginning January 7, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years